Technician Job Opportunity

BOPA is working in partnership with university of Liverpool who are developing a web based anticancer drug interactions resource. Please see advert below for editorial assistant.

Grade 6 Editorial Assistant in Drug Interactions involving anti-cancer drugs
This is an exciting opportunity to work with an internationally acknowledged group to develop a new website and Apps for Cancer Drug Interactions.  We are looking for a pharmacy technician or a pharmacology graduate who can assist in developing this new prescribing support tool, based on highly successful websites for HIV (www.hiv-druginteraction.org) and hepatitis (www.hep-druginteractions.org). 

Further details from the following:
https://recruit.liverpool.ac.uk/pls/corehrrecruit/erq_jobspec_version_4….
and attached JD.
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article